Page 19 - அக் சான் டியாகோ பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First Clinical Trial to Assess Alzheimer’s Gene Therapy Receives $5 Million News release The National Institute on Aging (NIA), part of the National Institutes of Health, has awarded a $5 million grant to researchers at University of California San Diego School of Medicine to conduct a first-in-human Phase 1 clinical trial of a gene therapy for treating Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia. Gene therapy is an experimental technique that uses genes or gene products to treat or prevent disease instead of relying on drugs or surgery. The clinical trial, developed by principal investigator Mark Tuszynski, MD, PhD, professor of neuroscience and director of the Translational Neuroscience Institute at UC San Diego School of Medicine, delivers the brain-derived neurotrophic factor (BDNF) gene into the brains of qualifying trial participants where it is hoped it will prompt production of BDNF in nearby cel

San diegoUnited statesUniversity of california san diegoMichelle mendozaMark tuszynskiDarlene shileyNational institutes of healthAlzheimer associationTranslational neuroscience instituteNational institute on agingUc san diego school of medicineNational instituteNational institutesCalifornia san diego schoolMild cognitive impairmentDiego school